Calcium Gluconate Treatment and Management

Clinical Uses and Indications

• For symptomatic hypocalcemia, administer calcium gluconate 50-100 mg/kg IV as a single dose, infused slowly with ECG monitoring, and cautiously repeat if necessary, as recommended by the Journal of Clinical Oncology and Haematologica 1, 2
• The American Academy of Pediatrics recommends 60 mg/kg of calcium gluconate intravenously, infused over 30-60 minutes, for mild hypocalcemia in pediatric patients 3
• Asymptomatic hypocalcemia does not require treatment in most cases, according to the Journal of Clinical Oncology and Haematologica 1, 2
• Calcium gluconate (100-200 mg/kg/dose) is administered via slow IV infusion with ECG monitoring for bradycardia to treat life-threatening arrhythmias from hyperkalemia, as stated in the Journal of Clinical Oncology 1
• This stabilizes the myocardial cell membrane without lowering potassium levels, as noted in Haematologica 2
• Sodium bicarbonate and calcium should never be administered through the same IV line, as warned by the Journal of Clinical Oncology 1
• For CCB poisoning with hemodynamic instability, administer 30-60 mL (3-6 grams) of 10% calcium gluconate IV every 10-20 minutes, or as a continuous infusion at 0.6-1.2 mL/kg/hour, as recommended by Praxis Medical Insights 3
• Alternatively, give 0.6 mL/kg of 10% calcium gluconate solution IV over 5-10 minutes, followed by an infusion of 0.3 mEq/kg per hour, titrated to hemodynamic response, as suggested by Praxis Medical Insights 4
• For β-blocker overdose with refractory shock, the American Heart Association suggests administering 0.3 mEq/kg of calcium (0.6 mL/kg of 10% calcium gluconate) IV over 5-10 minutes, followed by infusion of 0.3 mEq/kg per hour, as recommended by Praxis Medical Insights 4
• Calcium gluconate 60 mg/kg administered slowly is recommended by the American Academy of Pediatrics for pediatric patients with hypermagnesemia, as stated in Praxis Medical Insights 4

Critical Dosing Information

• Symptomatic hypocalcemia: 50-100 mg/kg IV, administered slowly, as recommended by the Journal of Clinical Oncology and Haematologica 1, 2

Critical Safety Considerations

• Continuous ECG monitoring is essential during administration, especially in patients receiving cardiac glycosides or with hyperkalemia, as emphasized by the Journal of Clinical Oncology, Haematologica, and Praxis Medical Insights 1, 2, 3
• Stop injection immediately if symptomatic bradycardia occurs, as advised by Praxis Medical Insights 3
• Calcium gluconate is preferred over calcium chloride for peripheral administration due to less tissue irritation, as noted by Praxis Medical Insights 3
• In patients with tumor lysis syndrome, calcium administration must be approached cautiously because increased calcium might increase the risk of calcium phosphate precipitation in tissues and consequential obstructive uropathy, as warned by the Journal of Clinical Oncology 1
• If phosphate levels are high, renal consultation may be necessary before calcium administration, as recommended by the Journal of Clinical Oncology 1

Monitoring Requirements

• Monitor ionized calcium levels during infusion, avoiding severe hypercalcemia (ionized calcium >2× upper limits of normal), as advised by Praxis Medical Insights 4

Important Clinical Pearls

• In cardiac arrest situations, the American Heart Association prefers calcium chloride over calcium gluconate due to more rapid increase in ionized calcium concentration, as recommended by Praxis Medical Insights 4